Content about South Korea

May 23, 2013
Touro College of Pharmacy graduates present capstone projects

The Touro College of Pharmacy awarded three graduating students for their research into drug interactions, pneumonia treatment and access to birth control pills.

NEW YORK — The Touro College of Pharmacy awarded three graduating students for their research into drug interactions, pneumonia treatment and access to birth control pills.

January 28, 2013
Amneal, South Korea-based Hanmi enter GERD drug deal

U.S. generic drug maker Amneal Pharmaceuticals has entered a deal with South Korean drug maker Hanmi Pharmaceutical to acquire exclusive distribution rights for a Hanmi drug used for treating gastroesophageal reflux disease, Amneal said Monday.

BRIDGEWATER, N.J. — U.S. generic drug maker Amneal Pharmaceuticals has entered a deal with South Korean drug maker Hanmi Pharmaceutical to acquire exclusive distribution rights for a Hanmi drug used for treating gastroesophageal reflux disease, Amneal said Monday.

December 12, 2012
Avon to cut jobs, exit two markets as part of cost-savings plan

Avon, a direct seller of beauty products, has outlined initial steps toward its previously announced cost-savings initiative, which includes the reduction of about 1,500 global jobs.

NEW YORK — Avon, a direct seller of beauty products, has outlined initial steps toward its previously announced cost-savings initiative, which includes the reduction of about 1,500 global jobs.

The company also announced that it will exit the South Korea and Vietnam markets. These actions are aimed at concentrating resources on high-priority markets and activities and boosting efficiencies, and are expected to be largely completed before the end of 2013, the company stated.

July 24, 2012
Kline: Once again, professional skin care market sees boost

The professional skin care products market realized a 5.3% gain in 2011, according to a new report from Kline.

PARSIPPANY, N.J. — The professional skin care products market realized a 5.3% gain in 2011, according to a new report from Kline.

In the latest "Professional Skin Care Global Series: Market Analysis and Opportunities" report,  Kline found that sales for the European market came close to pre-recession peak levels, rising 4%, while China and South Korea posted growth of 9.3% and 9.5%, respectively, within the professional sector.

January 18, 2012
Frost & Sullivan forecasts strong growth in generic drug market through 2017

Patent expirations of key blockbuster drugs and efforts by payers to contain costs are likely to bring strong growth to the global generic drug market in the next few years as market-earned revenues grow by more than $100 billion, according to an analysis by research firm Frost & Sullivan.

LONDON — Patent expirations of key blockbuster drugs and efforts by payers to contain costs are likely to bring strong growth to the global generic drug market in the next few years as market-earned revenues grow by more than $100 billion, according to an analysis by research firm Frost & Sullivan.

The report, titled "Generic Pharmaceuticals Market — A Global Analysis" and focusing on the United States and Europe, also found that healthcare expenditure and sales revenues are poised to shift to India, China, Brazil, Turkey and South Korea.

June 13, 2011
Merck, Hanwha to develop Enbrel biosimilar

Merck will collaborate with a Korean manufacturer to develop a biosimilar version of a drug used for autoimmune diseases.

WHITEHOUSE STATION, N.J. — Merck will collaborate with a Korean manufacturer to develop a biosimilar version of a drug used for autoimmune diseases.

Merck, which operates outside the United States and Canada as MSD to avoid confusion with Germany-based Merck KGaA, announced Monday a collaboration with Seoul, South Korea-based Hanwha Chemical to develop and commercialize HD203, a biosimilar version of Enbrel (etanercept), made by Amgen and Pfizer. The drug is used to treat such disorders as rheumatoid arthritis and psoriasis.

February 16, 2011
Report: Bank promotes fitness with account incentives

Lose weight. Get paid.

NEW YORK — Lose weight. Get paid.

That’s among the offerings at South Korea’s Hana Bank, according to published reports. Reuters reported Wednesday that the bank offers the “S-Line” program, whereby customers who burn calories, lose at least 5% of their body weight per year or hold a gym membership get a higher interest rate on their accounts.

The program, whose name refers to the Korean term for an hourglass physique, has existed since 2008.

December 22, 2010
J.R. Watkins Naturals expands its reach

J.R. Watkins Naturals is expanding its presence in the Asian market by selling its personal care and home care products through retail chains in Hong Kong, Japan and Taiwan.

WINONA, Minn. — J.R. Watkins Naturals is expanding its presence in the Asian market by selling its personal care and home care products through retail chains in Hong Kong, Japan and Taiwan.

"There is a growing demand for heritage brands and natural products in Asia, particularly in Hong Kong, South Korea, Japan and Taiwan," stated J.R. Rigley, J.R. Watkins Naturals' sales and marketing VP. "We are proud to bring more than 140 years of natural tradition to consumers in these countries."